Angeliq FDA Approval History
FDA Approved: Yes (First approved September 28, 2005)
Brand name: Angeliq
Generic name: drospirenone and estradiol
Dosage form: Tablets
Company: Berlex, Inc.
Treatment for: Postmenopausal Symptoms
Angeliq is a hormone replacement therapy containing estradiol and the progestin drospirenone, a hormone that counters the excess water and sodium buildup that is a side effect of estradiol. Angeliq is used to treat moderate to severe menopausal symptoms, such as hot flashes and vaginal dryness.
Development timeline for Angeliq
| Date | Article |
|---|---|
| Feb 29, 2012 | Approval U.S. FDA Approves Lower Dose Formulation of Angeliq (drospirenone and estradiol) Tablets |
| Sep 28, 2005 | Approval Angeliq Berlex, Inc. - Treatment for Menopausal Symptoms |
| Sep 15, 2004 | FDA Issues Approvable Letter to Berlex Laboratories for Angeliq |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
